// App-Quantinova.ai

: A hypothesis driven approach investigating the interleukin-6 pathway in UBIOPRED severe asthma patients

Researchers

Presenter

  • Nil Turan

Principal Investigators

  • Stewart Bates

  • Matthew Edwards

  • Dominick E Shaw

  • Kian Fan Chung

  • Anna James

  • Matthew J Loza

  • Antoon J. Van Oosterhout

Medical Centers

  • GSK, Respiratory Therapy Area Unit, Stevenage, United Kingdom

  • Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, Notts, United Kingdom

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Inst. of Environmental Medicine, Karolinska Institutet,Stockholm, Sweden

  • Janssen Research and Development, Spring House, PA, United States,

  • Academic Medical Center, Amsterdam, Netherlands

Locations

  • United Kingdom

  • Sweden

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • C reactive protein

  • Interleukin 6

  • Body mass index

Drug/Treatment

  • ILS-969

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved